Stem Cell Transplant Complications
📧 Sign up to get email alerts when something new happens for Stem Cell Transplant Complications.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-04-27Clinical Trial Update: A Study to Evaluate Tabelecleucel in Participants With Epstein Barr Virus (EBV) Associated Diseases [Phase 2]
Phase 2 clinical trial evaluating tabelecleucel in EBV-associated diseases is active/not recruiting, focusing on EBV+ LPD and related condit…
-
CLINICAL_TRIALS trial_result · 2024-09-04Clinical Trial Update: Ultrasound Elastography to Predict Development of SOS [NA]
Clinical trial using ultrasound elastography to predict sinusoidal obstruction syndrome in transplant patients has been terminated. Results …
-
CLINICAL_TRIALS trial_result · 2023-10-03Clinical Trial Update: A Safety Study of Liposomal Cyclosporine A to Treat Bronchiolitis After Hematopoietic Transplant (BOSTON-4) [Phase 2]
Phase 2 safety study of liposomal cyclosporine A for bronchiolitis after hematopoietic cell transplantation was terminated; results posted.
-
CLINICAL_TRIALS trial_result · 2022-02-25Clinical Trial Update: Prevention of C.Difficile Infections With Oral Vancomycine in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplant [Phase 3]
A Phase 3 trial evaluating oral vancomycin to prevent Clostridium difficile infections in patients undergoing allogeneic hematopoietic stem …
-
CLINICAL_TRIALS trial_result · 2021-12-14Clinical Trial Update: Low Dose Ruxolitinib in Combination With Methylprednisolone [Phase 1, Phase 2]
Clinical trial update for low-dose ruxolitinib combined with methylprednisolone in Phase 1/2 for acute graft-versus-host disease and stem ce…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2021-03-08Clinical Trial Update: Tocilizumab for Cytokine Release Syndrome Prophylaxis in Haploidentical Transplantation [Phase 1, Phase 2]
Phase 1/2 trial evaluating tocilizumab to prevent cytokine release syndrome after haploidentical stem cell transplantation has completed.
-
CLINICAL_TRIALS trial_result · 2021-03-05Clinical Trial Update: Cyclosporine on Day Zero as Prophylaxis for Cytokine Release Syndrome [Phase 2]
Phase 2 trial evaluating Day 0 cyclosporine as prophylaxis for cytokine release syndrome in stem cell transplant settings.
-
CLINICAL_TRIALS trial_result · 2020-12-10Clinical Trial Update: A Double-blind Randomized Placebo Controlled Clinical Trial Evaluating Effect of Chlorhexidine Gluconate 2% Cloth vs Placebo Cloth Baths on the Incidence of Central Line-Associated Blood Stream Infections in Outpatient Hematopoietic Stem Cell Transplant Patients [Phase 2]
Phase 2 double-blind randomized trial evaluating chlorhexidine gluconate 2% cloth baths versus placebo cloth baths to reduce central line-as…
-
CLINICAL_TRIALS trial_result · 2020-11-17Clinical Trial Update: A Randomized Phase IV Control Trial of Single High Dose Oral Vitamin D3 in Pediatric Patients Undergoing HSCT [Phase 4]
A Phase IV randomized trial evaluated a single high-dose oral vitamin D3 in pediatric patients undergoing stem cell transplantation; the stu…
-
CLINICAL_TRIALS trial_result · 2020-09-25Clinical Trial Update: Prolonged Isolated Thrombocytopenia After Allo-SCT : N-acetyl-L-cysteine (NAC) Versus Supportive Therapy [Phase 2, Phase 3]
Phase 2/3 trial comparing N-acetyl-L-cysteine (NAC) to supportive therapy for prolonged isolated thrombocytopenia after allogeneic stem cell…
-
CLINICAL_TRIALS trial_result · 2019-12-18Clinical Trial Update: Psychological Intervention for Caregivers of Patients Undergoing Hematopoietic Stem Cell Transplantation (HCT)
A completed clinical trial assessing a psychological intervention for caregivers of patients undergoing hematopoietic stem cell transplantat…
-
CLINICAL_TRIALS trial_result · 2019-05-29Clinical Trial Update: Decitabine Plus mBU/CY Preconditioning for Relapse/Refractory Acute Leukemia [Phase 2, Phase 3]
Clinical trial update on decitabine combined with mBU/CY preconditioning for relapse/refractory acute leukemia in Phase 2/Phase 3.